Safety of inhaled proteins for therapeutic use.
暂无分享,去创建一个
[1] J. Crapo,et al. Allometric relationships of cell numbers and size in the mammalian lung. , 1992, American journal of respiratory cell and molecular biology.
[2] C. Jefcoate. P450 Cytochromes and Hormonal Regulation: An Overview , 1996 .
[3] Y. Chien,et al. Systemic delivery of peptides and proteins across absorptive mucosae. , 1996, Critical reviews in therapeutic drug carrier systems.
[4] E. Weibel. Morphometry of the Human Lung , 1965, Springer Berlin Heidelberg.
[5] J. Patton,et al. Drug delivery via the respiratory tract. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[6] G. Smaldone,et al. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. , 1987, The American review of respiratory disease.
[7] K. Bensch,et al. Absorption of Intact Protein Molecules across the Pulmonary Air-Tissue Barrier , 1967, Science.
[8] E. G. Erdös,et al. Neutral metalloendopeptidase in human lung tissue and cultured cells. , 1985, The American review of respiratory disease.
[9] P. Byron. Respiratory Drug Delivery , 1989 .
[10] W. Thurlbeck. The internal surface area of nonemphysematous lungs. , 2015, The American review of respiratory disease.
[11] J. Patton,et al. Mechanisms of macromolecule absorption by the lungs , 1996 .
[12] R. Boucher. Human airway ion transport. Part one. , 1994, American journal of respiratory and critical care medicine.
[13] A. Sant'annaGandra. Aerosols in medicine , 1957 .
[14] H. Folkesson,et al. Permeability of the respiratory tract to different-sized macromolecules after intratracheal instillation in young and adult rats. , 1990, Acta physiologica Scandinavica.
[15] J. Dosman,et al. Characterization of health effects of grain dust exposures. , 1990, American Journal of Industrial Medicine.
[16] J. Brain,et al. Respiratory Defense Mechanisms , 1977 .
[17] B. Zinman. The Physiologic Replacement of Insulin , 1989 .
[18] J. Jones,et al. Rapid improvement in abnormal pulmonary epithelial permeability after stopping cigarettes , 1981, British medical journal.
[19] R. Elliott,et al. Parenteral absorption of insulin from the lung in diabetic children , 1987, Australian paediatric journal.
[20] S. Walford,et al. A Fifteen‐month Double‐blind Cross‐over Study of the Efficacy and Antigenicity of Human and Pork Insulins , 1984, Diabetic medicine : a journal of the British Diabetic Association.
[21] D H Bowden,et al. Dose response of the pulmonary macrophagic system to various particulates and its relationship to transepithelial passage of free particles. , 1981, Experimental lung research.
[22] D. Borson. Roles of neutral endopeptidase in airways. , 1991, The American journal of physiology.
[23] J. Whisstock,et al. Conformational Changes in Serpins and the Mechanism of α1-Antitrypsin Deficiency , 1994 .
[24] P. Holt,et al. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. , 1987, Immunology.
[25] L. Lazarus,et al. Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. , 1983, The Journal of clinical endocrinology and metabolism.
[26] R. Baumal,et al. Animal model of grain worker's lung. , 1986, Environmental health perspectives.
[27] J. Mauderly,et al. Particle Overload in Toxicological Studies: Friend or Foe? , 1990 .
[28] John F. Murray,et al. Textbook of Respiratory Medicine , 1988 .
[29] J. Patton,et al. (D) Routes of delivery: Case studies , 1992 .
[30] M. Karnovsky,et al. THE ULTRASTRUCTURAL BASIS OF ALVEOLAR-CAPILLARY MEMBRANE PERMEABILITY TO PEROXIDASE USED AS A TRACER , 1968, The Journal of cell biology.
[31] G. Fick,et al. Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. , 1989, Journal of applied physiology.
[32] R. Bick,et al. Clinical Use of Intrapulmonary Heparin , 1985, Seminars in thrombosis and hemostasis.
[33] M. Matthay,et al. Long-term clearance of liquid and protein from the lungs of unanesthetized sheep. , 1985, Journal of applied physiology.
[34] R. Crystal,et al. Aerosol α1 -antitrypsin treatment for cystic fibrosis , 1991, The Lancet.
[35] P. Holt. Immunoprophylaxis of atopy: light at the end of the tunnel? , 1994, Immunology today.
[36] L. Deftos,et al. Alveolar epithelial cells express and secrete parathyroid hormone-related protein. , 1994, American journal of respiratory cell and molecular biology.
[37] J. Crapo,et al. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. , 1997, Journal of applied physiology.
[38] P. Morrow,et al. Dust overloading of the lungs: update and appraisal. , 1992, Toxicology and applied pharmacology.
[39] G. K. Adams,et al. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. , 1993, JAMA.
[40] W. Solomon. Aerobiology of pollinosis. , 1984, The Journal of allergy and clinical immunology.
[41] R. Martin,et al. The effects of inhaled interferon gamma in normal human airways. , 1993, The American review of respiratory disease.
[42] Green Jd. Pharmaco-toxicological expert report Pulmozyme rhDNase Genentech, Inc. , 1994 .
[43] H. Folkesson,et al. Alveolar epithelial clearance of protein. , 1996, Journal of applied physiology.
[44] R. Wolff,et al. Toxicologic testing of inhaled pharmaceutical aerosols. , 1993, Critical reviews in toxicology.
[45] K. Cantell,et al. Effect of inhaled natural interferon-alpha on diffuse bronchioalveolar carcinoma. , 1990, European journal of cancer.
[46] Y. Sibille,et al. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulin M in bronchoalveolar lavage. , 1985, The American review of respiratory disease.
[47] H. Reynolds,et al. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. , 1974, The Journal of laboratory and clinical medicine.
[48] M. Jaurand,et al. Immunoelectron microscopic and immunochemical demonstrations of serum proteins in the alveolar lining material of the rat lung. , 1976, The American review of respiratory disease.
[49] J. Davidson,et al. Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin Mixtures , 1981, Diabetes Care.
[50] M. Perricaudet,et al. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety. , 1994, Gene therapy.
[51] T. Platts-Mills,et al. How environment affects patients with allergic disease: indoor allergens and asthma. , 1994, Annals of allergy.
[52] R. Crystal,et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis , 1994, Nature Genetics.
[53] T. Sweeney. Exposing Animals to Aerosols: Considerations That Influence Regional Lung Deposition , 1990 .
[54] R. Crystal,et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.
[55] W. Busse,et al. Asthma and Rhinitis , 1995 .
[56] M. Newhouse,et al. Sulfur dioxide and tracheobronchial clearance in man. , 1975, Archives of environmental health.
[57] D. Curiel,et al. Gene therapy approaches for inherited and acquired lung diseases. , 1996, American journal of respiratory cell and molecular biology.
[58] F. Morén,et al. Aerosols in Medicine: Principles, Diagnosis and Therapy , 1993 .
[59] J. Brain,et al. Pathways of clearance in mouse lungs exposed to iron oxide aerosols , 1975, The Anatomical record.
[60] D. Valeyre,et al. Glucose, K+, and albumin concentrations in the alveolar milieu of normal humans and pulmonary sarcoidosis patients. , 1991, The American review of respiratory disease.
[61] M. Matthay,et al. Clearance of different-sized proteins from the alveolar space in humans and rabbits. , 1992, Journal of applied physiology.
[62] M. Williams,et al. Endocytosis in alveolar type II cells: effect of charge and size of tracers. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Palmer,et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.
[64] R. Effros,et al. Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. , 1983, Chest.
[65] Wear Ll. Recent progress in protein and peptide delivery by noninvasive routes. , 1991 .
[66] Effros Rm,et al. Measurements of pulmonary epithelial permeability in vivo. , 1983, The American review of respiratory disease.
[67] C. Hall. Aerosolized Treatment of Acute Pulmonary Infections , 1989 .
[68] R. S. Pillai,et al. The effect of pulmonary-delivered insulin on blood glucose levels using two nebulizer systems. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[69] M. Welsh,et al. Safety and efficacy of repetitive adenovirus–mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats , 1994, Nature Genetics.
[70] M. Newhouse,et al. Deposition and fate of aerosolized drugs. , 1978, Chest.
[71] J. Caillon,et al. Lung distribution and pharmacokinetics of aerosolized tobramycin. , 1993, The American review of respiratory disease.
[72] T. Ahmed,et al. Variability of hypoxic pulmonary vasoconstriction in sheep. Role of prostaglandins. , 2015, The American review of respiratory disease.
[73] R. Niven,et al. Delivery of biotherapeutics by inhalation aerosol. , 1995, Critical reviews in therapeutic drug carrier systems.